COR logo Cencora +
Cencora
+

Cencora (COR) Business News

Track Cencora in real time with a live news feed covering Cencora stock news, official press releases, company announcements, and an archive of historical Cencora news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

Carillon Eagle Mid Cap Growth Fund Q2 2026 Portfolio Review

Seeking Alpha

8:53 AM | Tuesday | Jul 14, 2026

news photo
Loading...

Carillon Eagle Mid Cap Growth Fund stocks delivered solid results in the second quarter. Top securities in the quarter were Datadog, Marvell, Vertiv, Teradyne and Macom Technology Solutions. Top securities in the quarter were Datadog, Marvell, Vertiv, Teradyne and Macom Technology Solutions.

Read full article redirect
8:53 AM | Tuesday | Jul 14, 2026

Carillon Eagle Mid Cap Growth Fund Q2 2026 Portfolio Review

Seeking Alpha

Carillon Eagle Mid Cap Growth Fund stocks delivered solid results in the second quarter. Top securities in the quarter were Datadog, Marvell, Vertiv, Teradyne and Macom Technology Solutions. Top securities in the quarter were Datadog, Marvell, Vertiv, Teradyne and Macom Technology Solutions.

Read full article arrow
News Thumbnail
8:53 AM | Tuesday | Jul 14, 2026

Carillon Eagle Mid Cap Growth Fund Q2 2026 Portfolio Review

Seeking Alpha

Carillon Eagle Mid Cap Growth Fund stocks delivered solid results in the second quarter. Top securities in the quarter were Datadog, Marvell, Vertiv, Teradyne and Macom Technology Solutions. Top securities in the quarter were Datadog, Marvell, Vertiv, Teradyne and Macom Technology Solutions.

Read full article arrow
News Thumbnail
1:09 PM | Monday | Jul 6, 2026

Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?

Fool - Investing News

Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.

Read full article arrow
News Thumbnail
4:30 PM | Wednesday | Jul 1, 2026

Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release

Business Wire

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Third Quarter of Fiscal 2026 on Wednesday, August 5, 2026, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m.
ET on August 5, 2026. Participating in the conference call will be: Robert P. Mauch, President & Chief Executive Officer Eva C. Boratto, Executive Vice President & Chief.

Read full article arrow
News Thumbnail
11:36 AM | Thursday | Jun 18, 2026

Cencora Launches Enhanced Nucleus Solution for Specialty Practices

Zacks Investment Research

COR's enhanced Nucleus platform targets complex specialty medication workflows, with a pilot underway across more than 20 physician practice sites.

Read full article arrow
News Thumbnail
9:00 AM | Thursday | Jun 18, 2026

Bet on 5 Top-Ranked Stocks With Rising P/E for Solid Returns

Zacks Investment Research

Rising P/E ratios can signal confidence and momentum. Discover 5 stocks backed by strong earnings growth and upside potential.

Read full article arrow
News Thumbnail
9:56 AM | Wednesday | Jun 17, 2026

Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns

Zacks Investment Research

The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. TPR, VRT, CLS and COR are some such stocks.

Read full article arrow
News Thumbnail
8:00 AM | Wednesday | Jun 17, 2026

Cencora Launches Next-Generation Nucleus® Solution with Multi-Site Pilot Across Specialty Physician Practices

Business Wire

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global pharmaceutical solutions company, today announced a multi-site pilot of its enhanced Nucleus® inventory management solution, designed to help specialty physician practices manage increasingly complex medication workflows with greater efficiency, visibility and control. Developed with input from customer advisory boards and specialty care providers, the updated platform combines redesigned physical infrastructure with software and interface e.

Read full article arrow
News Thumbnail
4:15 PM | Monday | Jun 15, 2026

Cencora Announces Samantha Hammock as Chief Human Resources Officer

Business Wire

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that Silvana Battaglia, Executive Vice President and Chief Human Resources Officer (CHRO), has announced she will retire from the company following a distinguished seven-year tenure. She will be succeeded by Samantha (Sam) Hammock, who will join Cencora as Executive Vice President and CHRO, effective July 13, 2026. "During her seven years of leadership, Silvana has made critical, lasting contributions to Cencora durin.

Read full article arrow
News Thumbnail
10:45 AM | Tuesday | Jun 9, 2026

2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now

The Motley Fool

The shares of both stocks are down so far this year. Stevanato is benefiting from the need for GLP-1 injectables.

Read full article arrow
News Thumbnail
12:36 PM | Friday | Jun 5, 2026

Cencora (COR) Up 5.7% Since Last Earnings Report: Can It Continue?

Zacks Investment Research

Cencora (COR) reported earnings 30 days ago. What's next for the stock?

Read full article arrow
News Thumbnail